Immunohistochemical Analysis Still Has a Limited Role in the Diagnosis of Malignant Mesothelioma-Reference-Cited by-同舟云学术

Immunohistochemical Analysis Still Has a Limited Role in the Diagnosis of Malignant Mesothelioma

Published:2001-08 Issue:2 Volume:116 Page:253-262
ISSN:0002-9173
Container-title:American Journal of Clinical Pathology
language:en
Short-container-title:Am J Clin Pathol

Author:

Roberts Fiona,Harper Christina M.,Downie Ian,Burnett Rodney A.

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/ajcp/article-pdf/116/2/253/4984234/ajcpath116-0253.pdf

Reference38 articles.

1. Peto J, Hodgson J, Matthews FE, et al. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345:535-539.

2. De Vos Irvine H. Mesothelioma [letter]. Lancet. 1995; 345:1233.

3. Dorward A, Stack B. Diffuse malignant pleural mesothelioma in Glasgow. Br J Dis Chest. 1981;75:397-402.

4. Wang N, Huang S, Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohisto-chemical differentiation from other lung cancers. Cancer. 1979;44:937-943.

5. Collins C, Ordonez N, Schaefer R, et al. Thrombomodulin expression in malignant pleural mesothelioma and pulmonary adenocarcinoma. Am J Pathol. 1992;141:827-833.

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunocytochemistry of effusions: Processing and commonly used immunomarkers;Cytojournal;2022-01-31

2. Exfoliative Cytology and Effusions;Handbook of Practical Immunohistochemistry;2022

3. Significance of p53 immunostaining in mesothelial proliferations and correlation with TP53 mutation status;Modern Pathology;2021-09-08

4. High tumor cell platelet‐derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma;The Journal of Pathology: Clinical Research;2021-05-06

5. A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma;Lung Cancer;2020-04